383 related articles for article (PubMed ID: 18547346)
1. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
Nonaka D; Chiriboga L; Rubin BP
J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
4. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
Fullen DR; Garrisi AJ; Sanders D; Thomas D
J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
[TBL] [Abstract][Full Text] [Related]
5. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
6. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
Lazova R; Tantcheva-Poor I; Sigal AC
J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
[TBL] [Abstract][Full Text] [Related]
7. Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors.
Dundr P; Povýsil C; Tvrdík D
Pathol Int; 2009 Feb; 59(2):86-90. PubMed ID: 19154261
[TBL] [Abstract][Full Text] [Related]
8. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
9. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas.
Chijiwa K; Uchida K; Tateyama S
Vet Pathol; 2004 Jul; 41(4):307-18. PubMed ID: 15232130
[TBL] [Abstract][Full Text] [Related]
11. Feline cutaneous nerve sheath tumours: histological features and immunohistochemical evaluations.
Mandara MT; Fabriani E; Pavone S; Pumarola M
Res Vet Sci; 2013 Oct; 95(2):548-55. PubMed ID: 23659741
[TBL] [Abstract][Full Text] [Related]
12. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
[TBL] [Abstract][Full Text] [Related]
13. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
14. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
[TBL] [Abstract][Full Text] [Related]
15. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
[TBL] [Abstract][Full Text] [Related]
16. Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
Shimada S; Tsuzuki T; Kuroda M; Nagasaka T; Hara K; Takahashi E; Hayakawa S; Ono K; Maeda N; Mori N; Illei PB
Pathol Int; 2007 Feb; 57(2):60-7. PubMed ID: 17300669
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
Salla JT; Johann AC; Lana AM; do Carmo MA; Nunes FD; Mesquita RA
Oral Dis; 2008 Sep; 14(6):510-3. PubMed ID: 18826382
[TBL] [Abstract][Full Text] [Related]
18. Immunoprofiles in malignant peripheral nerve sheath tumor: three case reports and literature review.
Hu SW; Lin WC; Tsai HJ; Chien SH; Tsai KB
Kaohsiung J Med Sci; 2006 Mar; 22(3):135-42. PubMed ID: 16602278
[TBL] [Abstract][Full Text] [Related]
19. Superficial malignant peripheral nerve sheath tumor: a rare and challenging diagnosis.
Allison KH; Patel RM; Goldblum JR; Rubin BP
Am J Clin Pathol; 2005 Nov; 124(5):685-92. PubMed ID: 16203275
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of IRS2 in the progression from neurofibroma to malignant peripheral nerve sheath tumor.
Shaw CM; Grobmyer SR; Ucar DA; Cance WG; Reith JD; Hochwald SN
Anticancer Res; 2012 Feb; 32(2):439-43. PubMed ID: 22287730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]